The Perils of Submitting
Q-Subs to FDA During the COVID-19 Pandemic

Gain insight into how the COVID-19 pandemic has impacted the United States Food and Drug Administration’s (“FDA”) Q-Sub program with R&Q’s easy-to-understand whitepaper. Our experts will walk you through:

The Basics: What is a Q-Sub?
FDA’s Current Challenges
COVID-19 Impact on FDA Q-Sub Program
What You Can Do to Increase Your Chances of Q-Sub Success

Avoid common Q-Sub downfalls and understand what is really happening with the FDA’s Q-Sub program. Download R&Q’s whitepaper!

First Name *

Last Name *

Email *

Company Name *

Company Type *

Job Function *

Job Level *

Dive Publication

Field will not be visible to web visitor

By completing this form, you agree to our Terms of Use, Privacy Policy, and your information being shared with our sponsor, R&Q.*

The Perils of Submitting Q-Subs to FDA During the COVID-19 Pandemic

GET THE WHITEPAPER

Form submitted successfully.

Please verify your mobile number

The Perils of Submitting
Q-Subs to FDA During the COVID-19 Pandemic